Downes MR - Search Results

1

2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer.

Byrne JC, Downes MR, O'Donoghue N, O'Keane C, O'Neill A, Fan Y, Fitzpatrick JM, Dunn M, Watson RW. Byrne JC, et al. Among authors: downes mr. J Proteome Res. 2009 Feb;8(2):942-57. doi: 10.1021/pr800570s. J Proteome Res. 2009. PMID: 19093873

2

Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review.

Downes MR, Byrne JC, Dunn MJ, Fitzpatrick JM, Watson RW, Pennington SR. Downes MR, et al. Biomarkers. 2006 Sep-Oct;11(5):406-16. doi: 10.1080/13547500600799821. Biomarkers. 2006. PMID: 16966158 Review.

3

Urinary markers for prostate cancer.

Downes MR, Byrne JC, Pennington SR, Dunn MJ, Fitzpatrick JM, Watson RW. Downes MR, et al. BJU Int. 2007 Feb;99(2):263-8. doi: 10.1111/j.1464-410X.2006.06610.x. Epub 2006 Dec 1. BJU Int. 2007. PMID: 17092277 Review.

4

Fasting status as a consideration for human serum collection and preparation prior to depletion and analysis.

Byrne JC, Downes MR, O'Donoghue N, Fitzpatrick JM, Dunn MJ, Watson RW. Byrne JC, et al. Among authors: downes mr. Electrophoresis. 2008 Jul;29(14):3055-9. doi: 10.1002/elps.200700933. Electrophoresis. 2008. PMID: 18551713

5

Detecting soluble clusterin in in-vitro and in-vivo models of prostate cancer.

Girard FP, Byrne J, Downes M, Fanning D, Desgrandchamps F, Fitzpatrick JM, Watson RW. Girard FP, et al. Neoplasma. 2010;57(5):488-93. doi: 10.4149/neo_2010_05_488. Neoplasma. 2010. PMID: 20568904

6

Analysis of trends and seasonal variation in primary cutaneous melanoma: an Irish study.

Downes MR, Fan Y, Murphy G, Gulmann C. Downes MR, et al. Clin Exp Dermatol. 2011 Jun;36(4):374-7. doi: 10.1111/j.1365-2230.2010.03952.x. Clin Exp Dermatol. 2011. PMID: 21251243

7

Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma.

Downes MR, Torlakovic EE, Aldaoud N, Zlotta AR, Evans AJ, van der Kwast TH. Downes MR, et al. J Clin Pathol. 2013 Sep;66(9):779-86. doi: 10.1136/jclinpath-2013-201586. Epub 2013 Jun 17. J Clin Pathol. 2013. PMID: 23775437

8

Evaluation of ERG and PTEN protein expression in cribriform architecture prostate carcinomas.

Downes MR, Satturwar S, Trudel D, van der Kwast TH. Downes MR, et al. Pathol Res Pract. 2017 Jan;213(1):34-38. doi: 10.1016/j.prp.2016.10.007. Epub 2016 Oct 26. Pathol Res Pract. 2017. PMID: 27913052

9

Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?

Olkhov-Mitsel E, Hodgson A, Liu SK, Vesprini D, Bayani J, Bartlett JMS, Xu B, Downes MR. Olkhov-Mitsel E, et al. Among authors: downes mr. Pathol Res Pract. 2020 Nov;216(11):153200. doi: 10.1016/j.prp.2020.153200. Epub 2020 Sep 5. Pathol Res Pract. 2020. PMID: 33022560

10

Profile of sudden death in an adult population (1999-2008).

Downes MR, Thorne J, Tengku Khalid TN, Hassan HA, Leader M. Downes MR, et al. Ir Med J. 2010 Jun;103(6):183-4. Ir Med J. 2010. PMID: 20669604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters